loadpatents
name:-0.020157098770142
name:-0.024029970169067
name:-0.0015239715576172
BOTTONI; Giuseppe Patent Filings

BOTTONI; Giuseppe

Patent Applications and Registrations

Patent applications and USPTO patent grants for BOTTONI; Giuseppe.The latest application filed is for "pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease".

Company Profile
1.21.20
  • BOTTONI; Giuseppe - BOLOGNA IT
  • Bottoni; Giuseppe - Bergamo IT
  • Bottoni; Giuseppe - Cinisello Balsamo IT
  • Bottoni; Giuseppe - Cusano Milanino IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20210244714 - VISCOMI; Giuseppe Claudio ;   et al.
2021-08-12
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 10,280,177 - Maffei , et al.
2019-05-07
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaxmin
App 20170101417 - MAFFEI; Paola ;   et al.
2017-04-13
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20170071916 - VISCOMI; Giuseppe Claudio ;   et al.
2017-03-16
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20150080421 - VISCOMI; Giuseppe Claudio ;   et al.
2015-03-19
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaxmin
App 20150072002 - MAFFEI; Paola ;   et al.
2015-03-12
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 8,748,449 - Maffei , et al. June 10, 2
2014-06-10
Mucoadhesive Xyloglucan-containing Formulations Useful In Medical Devices And In Pharmaceutical Formulations
App 20130183325 - BOTTONI; Giuseppe ;   et al.
2013-07-18
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin
App 20130072676 - MAFFEI; Paola ;   et al.
2013-03-21
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20120245192 - Viscomi; Giuseppe Claudio ;   et al.
2012-09-27
Compositions Comprising Nonsteroidal Anti - Inflammatory Drugs
App 20120238630 - Viscomi; Giuseppe Claudio ;   et al.
2012-09-20
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 8,217,054 - Maffei , et al. July 10, 2
2012-07-10
Mucoadhesive Xyloglucan-containing Formulations Useful In Medical Devices And In Pharmaceutical Fromulations
App 20120088726 - Bottoni; Giuseppe ;   et al.
2012-04-12
Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
App 20090081133 - Bottoni; Giuseppe ;   et al.
2009-03-26
Therapeutic compositions for intranasal administration which include KETOROLAC
Grant 7,476,689 - Santus , et al. January 13, 2
2009-01-13
Therapeutic compositions for intranasal administration which include KETOROLAC
Grant 7,267,827 - Santus , et al. September 11, 2
2007-09-11
Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds
Grant 7,157,099 - Autuori , et al. January 2, 2
2007-01-02
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 7,005,421 - Gatti , et al. February 28, 2
2006-02-28
Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives
Grant 6,984,632 - Mascagni , et al. January 10, 2
2006-01-10
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
App 20050282759 - Gatti, Gaetano ;   et al.
2005-12-22
Therapeutic compositions for intranasal administration which include KETOROLAC
App 20040171666 - Santus, Giancarlo ;   et al.
2004-09-02
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
App 20040077560 - Gatti, Gaetano ;   et al.
2004-04-22
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
App 20040077559 - Gatti, Gaetano ;   et al.
2004-04-22
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 6,632,799 - Gatti , et al. October 14, 2
2003-10-14
Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds
App 20030171299 - Autuori, Francesco ;   et al.
2003-09-11
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 6,596,697 - Gatti , et al. July 22, 2
2003-07-22
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
App 20030013666 - Gatti, Gaetano ;   et al.
2003-01-16
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
App 20020077303 - Gatti, Gaetano ;   et al.
2002-06-20
Therapeutic compositions for intranasal administration which include ketorolac
App 20020077346 - Santus, Giancarlo ;   et al.
2002-06-20
Therapeutic compositions for intranasal administration which include KETOROLAC.RTM.
Grant 6,333,044 - Santus , et al. December 25, 2
2001-12-25
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 6,107,285 - Gatti , et al. August 22, 2
2000-08-22
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 5,977,082 - Gatti , et al. November 2, 1
1999-11-02
Liquid-suspension controlled-release pharmaceutical composition
Grant 5,670,171 - Santus , et al. September 23, 1
1997-09-23
Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
Grant 5,571,533 - Santus , et al. November 5, 1
1996-11-05
Liquid-suspension controlled-release pharmaceutical composition
Grant 5,527,545 - Santus , et al. June 18, 1
1996-06-18
Pharmaceutical controlled-release composition with bioadhesive properties
Grant 5,472,704 - Santus , et al. December 5, 1
1995-12-05
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 5,124,317 - Gatti , et al. * June 23, 1
1992-06-23
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 5,124,318 - Gatti , et al. * June 23, 1
1992-06-23
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
Grant 4,946,831 - Gatti , et al. August 7, 1
1990-08-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed